Nova Patents
MX374652B

Assays for detecting the presence or amount of an anti-drug antibody

Abstract

Methods and kits for detecting antibodies (e.g., anti-drug antibodies). Such methods and kits permit the detection of, for example, anti-drug antibodies in human body fluids, such as blood, plasma and serum.

Term

9.9 yearsleft in the term

Expires 10 August 2036.

  1. Priority
  2. Filed
  3. Granted
  4. Today
  5. Expires

41 members in 19 offices

This recordMember, by publication datePriority claim9 more offices are in the list below

Priority claims2

Priority claims
DocumentOfficeKindDate
201461938556United States of AmericaP
2015015442United States of AmericaW

Members41

Family members, oldest first
DocumentOfficeKind
US2015226758A1United States of AmericaA1
CA2939080A1CanadaA1
WO2015123315A1World Intellectual Property Organization (WIPO)A1
SG11201606291VASingaporeA
AU2015217261A1AustraliaA1
CN106164670AChinaA
MX2016010413AMexicoA
EP3105592A1European Patent Office (EPO)A1
US9759732B2United States of AmericaB2
US2018088140A1United States of AmericaA1
EP3105592B1European Patent Office (EPO)B1
EP3422001A1European Patent Office (EPO)A1
PT3105592TPortugalT
LT3105592TLithuaniaT
DK3105592T3DenmarkT3
TR2019000160T4TürkiyeT4
TR201900160T4TürkiyeT4
HRP20190026T1CroatiaT1
SI3105592T1SloveniaT1
ES2705403T3SpainT3
RS58212B1SerbiaB1
PL3105592T3PolandT3
HUE041669T2HungaryT2
CN106164670BChinaB
SG10201906750XASingaporeA
EP3422001B1European Patent Office (EPO)B1
CY1121341T1CyprusT1
EP3667321A1European Patent Office (EPO)A1
AU2015217261B2AustraliaB2
MX2020009021AMexicoA
AU2020264316A1AustraliaA1
US11215623B2United States of AmericaB2
US2022187327A1United States of AmericaA1
EP3667321B1European Patent Office (EPO)B1
EP4137816A1European Patent Office (EPO)A1
US11927596B2United States of AmericaB2
US2024288454A1United States of AmericaA1
MX374652BThis recordMexicoB
EP4137816B1European Patent Office (EPO)B1
EP4582812A2European Patent Office (EPO)A2
EP4582812A3European Patent Office (EPO)A3